NELYA CURRY: Open Payments
NPI 1174875934 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 13 payments from 6 companies in 2025. Trend: 2023 $346 · 2024 $216 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $248 |
| Alkermes, Inc. | 4 | $198 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Lundbeck LLC | 1 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
Products named: CAPLYTA, REXULTI, LYBALVI, ARISTADA, FANAPT, INGREZZA.
Industry payments across OR — which companies pay providers there.
